Literature DB >> 11079577

Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs.

H Zhao1, S H Cheng, N S Yew.   

Abstract

The DNA of bacteria and many viruses contain unmethylated CpG dinucleotides in particular sequence contexts that activate vertebrate immune cells. A subset of these CpG motifs was previously found to oppose the effects of immunostimulatory (CpG-S) motifs and has been termed neutralizing (CpG-N) motifs. Here we show that oligodeoxynucleotides (ODNs) composed of clusters of CpG-N motifs could partially inhibit the induction of interleukin-12 (IK-12) from mouse spleen cells by ODN containing CpG-S motifs. However, non-CpG-containing ODN were also inhibitory, suggesting that neutralization of CpG-S ODNs by CpG-N ODNs in trans was nonspecific. Neutralization of CpG-S motifs by CpG-N motifs in cis was specific, but the degree of inhibition was strongly dependent on the particular CpG-S motif being neutralized, with motifs having an A residue 5' to the CG being much more resistant to inhibition than motifs having a T residue 5' to the CG. The degree of inhibition was dependent on the spacing between the CpG-S and CpG-N motifs, with the ability to neutralize inversely correlating with distance. In addition, whereas ODNs containing extended clusters of CpG-N motifs were nonstimulatory, isolated CpG-N motifs remained stimulatory in most sequence contexts. Finally, CpG-N ODNs were shown to be nonstimulatory when instilled into the lungs of BALB/c mice, but the ability of CpG-N motifs to neutralize CpG-S motifs in cis was not observed. These results show that there are precise and fairly complex interactions between immunostimulatory and inhibitory sequence motifs that govern whether a given DNA is able to activate the vertebrate immune system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079577     DOI: 10.1089/oli.1.2000.10.381

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  4 in total

Review 1.  Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.

Authors:  Ethlinn V B van Gaal; Wim E Hennink; Daan J A Crommelin; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

Review 2.  Microbe-dendritic cell dialog controls regulatory T-cell fate.

Authors:  John R Grainger; Jason A Hall; Nicolas Bouladoux; Guillaume Oldenhove; Yasmine Belkaid
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

Review 3.  Gene therapy for cystic fibrosis.

Authors:  Christian Mueller; Terence R Flotte
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

4.  Regulatory role of suppressive motifs from commensal DNA.

Authors:  N Bouladoux; J A Hall; J R Grainger; L M dos Santos; M G Kann; V Nagarajan; D Verthelyi; Y Belkaid
Journal:  Mucosal Immunol       Date:  2012-05-23       Impact factor: 7.313

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.